The raised guidance and strong cash flow suggest continued momentum. Watch for MACI U.K. launch in 2027 and potential FDA approval for ankle indication as catalysts.
How the stock moved after the report
⚠ Clustered BULLISH VIEWSTOCK ABOVE ENTRY AT T+5- T+0 · Nov 5 $51.78entry
- T+1 · 11d ago +5.48%α +5.17% · $54.62
- T+5 · 5d ago +10.89%α +7.60% · $57.42
- T+7 · todayOpen
- T+20 · in 17d Pending
- T+60 · in 3mo Pending
Price Chart
REPLAYWatch the reaction play outHow similar events traded
Executive Summary
Vericel reported Q3 2026 revenue of $85.4M (+26% YoY) and GAAP EPS of $0.27, well above the $0.06 consensus. The company raised full-year revenue guidance to $344-346M and adjusted EBITDA margin guidance to 28%, driven by strong MACI and Burn Care growth.
Key Financial Metrics
Key Facts
- Q3 2026 total revenue $85.4M, +26% YoY vs $67.5M
- GAAP diluted EPS $0.27 vs consensus $0.06 (beat by 350%)
- MACI revenue $67.4M, +21% YoY
- Burn Care revenue $18.0M, +52% YoY (Epicel $12.7M, NexoBrid $5.3M)
- Non-GAAP adjusted EBITDA $25.2M, 30% margin vs 25% a year ago
- Operating cash flow $17.7M, free cash flow $15.7M
- Raised full-year revenue guidance to $344-346M from $330-340M
- Raised MACI guidance to $290-292M from $284-290M
- Raised Burn Care guidance to $54M from $46-50M
- Raised adjusted EBITDA margin guidance to 28% from 27%
- Repurchased 220,744 shares for $8.8M in Q3
Financial Impact
Revenue beat consensus by $7.4M (9.5%); EPS beat by $0.21 (350%); guidance raised by $14M at midpoint
Segment Breakdown
| Segment | Revenue | Growth |
|---|---|---|
| MACI | $67.4M | +21.0% |
| Burn Care | $18.0M | +52.0% |
Risk Factors
- Guidance assumes continued MACI and Burn Care growth; any slowdown could reverse sentiment
- Dependence on MACI (79% of revenue); competitive or reimbursement changes could impact
- Supply chain risks from Middle East conflicts affecting NexoBrid supply
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 1 press release from GlobeNewswire.
| Document | Accession Number |
|---|---|
| PRESS-RELEASE Data (Synthetic) | press-3396327 |
Track record
30 reports on VCEL
1 of 3 bullish or bearish reports moved the stock their way by T+60. Best: +31.08% at T+60 after the May 7, 2026 report. 1 of 3 went positive at some point.
Filters
- Nov 13, 20263d ago 144 Neutral 2/10 Entry $56.96 Now $57.48 +0.91% settles Feb 11
- Nov 12, 20264d ago Insider Cluster Neutral 3/10 Entry $56.96 Now $57.48 +0.91% settles Feb 11
- Nov 12, 20264d ago 144 Neutral 1/10 Entry $57.42 Now $57.48 +0.10% settles Feb 10
- Nov 10, 20266d ago 144 Neutral 2/10 Entry $59.03 Now $57.48 −2.63% settles Feb 8
- Nov 9, 20267d ago 144 Neutral 2/10 Entry $59.03 Now $57.48 −2.63% settles Feb 8
- Nov 9, 20267d ago 144 Neutral 3/10 Entry $59.03 Now $57.48 −2.63% settles Feb 8
- Nov 9, 20267d ago Insider Cluster Neutral 2/10 Entry $59.03 Now $57.48 −2.63% settles Feb 8
- Nov 6, 202610d ago 144 Neutral 2/10 Entry $58.39 Now $57.48 −1.56% settles Feb 5
- Nov 6, 202610d ago Insider Cluster Neutral 2/10 Entry $58.39 Now $57.48 −1.56% settles Feb 5
- Nov 5, 202611d ago 144 Neutral 2/10 Entry $54.62 Now $57.48 +5.24% settles Feb 4
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers